Finerenone
RxNorm 2562811
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2562811 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: finerenone.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Finerenone
(Atom ID: 12655524)
PTPrescribable
Designated preferred name (PT):
Finerenone
(Atom ID: 12725833)
FNPrescribable
Full form of descriptor (FN):
Finerenone (substance)
(Atom ID: 12725834)
PTPrescribable
Designated preferred name (PT):
Finerenone-containing product
(Atom ID: 12725839)
FNPrescribable
Full form of descriptor (FN):
Product containing finerenone (medicinal product)
(Atom ID: 12726671)
Patient Education
Finerenone
Finerenone is used to treat adults with chronic kidney disease (damage to the kidneys which may worsen over time and may cause the kidneys to stop working) due to type 2 diabetes. This treatment may reduce the risk of worsening kidney disease, needing to be hospitalized for heart failure, and life-threatening heart and blood vessel disease or a heart attack. Finerenone is in a class of medications called mineralocorticoid receptor (MR) antagonists. It works by blocking the activity of certain steroids made in the body that can damage the heart and kidneys.
[Learn More]
* Please review the disclaimer below.